The emerging spectrum of COVID-19 neurology: clinical, radiological and laboratory findings

By Ross W. Paterson, Rachel L. Brown, Laura A. Benjamin, R. Nortley, Sarah Wiethoff, T. Bharucha, D. Jayaseelan, Guru Kumar, R. Raftopoulos, L. Zambreanu and 46 more. Brain : a journal of neurology, 2020

990 citations recorded by the source corpus.

Paterson, Brown et al. present a case series of 43 patients with neurological complications of SARS-CoV-2 infection. The neurological syndromes include encephalopathies, encephalitis, acute disseminated encephalomyelitis with haemorrhagic change, transverse myelitis, ischaemic stroke, and Guillain-Barré syndrome.

Subfields: Infectious Diseases, Neurology

View Paper: https://www.semanticscholar.org/paper/071d813e783d33f81e06e8925a74aadbfec6b8db

How researchers see this paper

The researchers whose trusted networks rank it highest, strongest advocate first. Every researcher gets a different order.

In Neurology

1. Stephen M. Smith
2. S. Yong

Citations in the corpus

• SARS-CoV-2 is associated with changes in brain structure in UK Biobank (2022, methodology): “Among those, some participants were identified as having been infected with SARS-CoV-2 based on: (1) the results of diagnostic antigen tests identified through linkage to health-related records, (2) their primary care (GP) data or hospital records, or (3) the results of two antibody tests.”
• Long COVID or post-COVID-19 syndrome: putative pathophysiology, risk factors, and treatments (2021, background): “Another study documenting 43 cases of COVID-19-induced serious brain diseases (e.g. encephalopathies, delirium, haemorrhage, and stroke) also found that initial COVID-19 severity plays little role in predicting these brain diseases [68].”